Categories: Esports

Unmatched Grit, Major Glory: J.J. Spaun Conquers Oakmont to Win First Major Championship

HUNTINGTON BEACH, Calif., June 15, 2025 – With unwavering resilience and poise, Srixon staffer J.J. Spaun delivered a major championship breakthrough at the 2025 U.S. Open, conquering the brutal test of Oakmont Country Club to claim his first major championship title.

- Advertisement -

The victory comes just months after Spaun’s close-call at The PLAYERS Championship – a near miss that tested his resolve but was important for his confidence moving forward. Despite mounting championship pressure and tough elements all day, Spaun remained calm after a shaky start that included a 5-over 40 to open his front nine. After an extended weather delay, Spaun started four back after the turn and hit the reset button. He would go on to fire an incredible 3-under 32, punctuated by a 64-foot birdie putt on the 18th green to finish the tournament at 1-under-par and two clear of the field.

- Advertisement -
I never thought I would be here holding this trophy. I’ve always had aspirations and dreams, but like I said a few months ago, I never knew what my ceiling was. I never knew how good I could be, but I’m just proud I’ve been resilient in my career and pushed through a lot of things. Just trying to be the best golfer I can be, and I’m happy to be able to display that today at Oakmont.
J.J. Spaun, Srixon Staffer
J.J. Spaun at the 2025 U.S. Open

Spaun surged to an early lead with a historic front-nine 31 in Thursday’s opening round—the lowest ever recorded at Oakmont in U.S. Open history. That momentum carried through the week as he battled both the field and the course’s demands. Leaning heavily on his Srixon Irons and Cleveland Wedges, Spaun highlighted his precision and creativity around the greens, finishing T9 in greens in regulation and inside the top 20 in strokes gained: around the greens.

- Advertisement -

This is Spaun’s second career victory and wins the U.S. Open in only his second appearance. He now moves into sixth position in the FedExCup rankings.

- Advertisement -

With an electric finish on one of the most challenging courses in the world, Spaun was the only player to finish under par. His performance not only etched his name into major championship history but highlights the elite tools he used to get there.

- Advertisement -
J.J. Spaun – 2025 U.S. Open Champion

Take a look at the winning set-up of the 2025 U.S. Open Champion:

- Advertisement -
  • Srixon ZXi5 Iron (4i)
  • Srixon ZXi7 Irons (5i-PW)
  • Cleveland Golf RTX ZipCore Wedge (50°)
  • Cleveland Golf RTZ Wedge (54° FULL)
  • Cleveland Golf RTX 6 ZipCore (60° LOW)
  • Srixon Z-STAR DIAMOND Golf Ball

To celebrate J.J. Spaun’s historic victory, Srixon is extending its major golf ball promotion through June 22, 2025, giving golfers the chance to play the same tour-proven ball trusted by the U.S. Open champion.

- Advertisement -

For full details on the equipment Spaun used to conquer Oakmont—including the Srixon ZXi Irons, Z-STAR DIAMOND golf ball, and Cleveland Golf Wedges, visit us.dunlopsports.com.

- Advertisement -
TheNews Market

Recent Posts

Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: Ocular Therapeutix, Inc. BEDFORD, Mass., Feb. 06, 2026…

2 hours ago

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI,…

2 hours ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing…

2 hours ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies

AlUla, Saudi Arabia, Feb. 7, 2026 /PRNewswire/ -- The second edition of the AlUla Conference…

2 hours ago

Roches fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS)

Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint…

2 hours ago

Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

February 06, 2026 17:17 ET  | Source: Lexicon Pharmaceuticals, Inc. THE WOODLANDS, Texas, Feb. 06,…

2 hours ago